Skip to main navigation Skip to search Skip to main content

An Open-Label, Randomized, Phase II/III Trial of Taxane Therapy With or Without Bavituximab for the Treatment of HER2-Negative Metastatic Breast Cancer

Project: Research

Project Details

StatusFinished
Effective start/end date07/26/16 → 07/26/17

Funding

  • Peregrine: $650.00